$NVST

Envista Holdings Corp (NVST): Results of Operations and Financial Condition

Envista Holdings Corp (NVST) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Envista Reports Second Quarter 2026 Results BREA, Calif., August 5, 2026 / PRNewswire / -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended July 3, 2026. “We built on our fast start in Q1 with continued good performance in Q2,”

Original reporting
Published Aug 5, 2026, 8:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NVST
Bullish
high confidence
Mentioned
$NVST
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NVSTBullishHigh
01

Why it matters

The key new tradable information is the combination of Q2 operating performance (including margin expansion and free cash flow) and the explicit increase to FY 2026 guidance ranges.

02

Market read

A guidance raise tied to margin expansion and cash flow is a direct input to FY valuation models and near-term positioning.

03

What to watch

The release emphasizes adjusted metrics and core sales; traders should scrutinize GAAP-to-adjusted reconciliation and whether free cash flow conversion remains near 100% through the second half.

Relevance 7/10Novelty 9/10Timing: after-hours filing on Aug 5, 2026, ahead of the investor call at 2:00 PM PT
AlphAI · Earnings readNVST · Second Quarter 2026 · ended July 3, 2026

Envista Reports Second Quarter 2026 Results

Strong quarter

Second-quarter core sales growth was 5.0%, adjusted diluted EPS increased 58% year-on-year, adjusted EBITDA increased 28% year-on-year, and the company raised its full-year 2026 outlook for core sales growth, adjusted EBITDA growth, and adjusted diluted EPS.

EPS · non-GAAP
$0.41
+58% year-on-year y/y

Key metrics

as reported
MetricValueq/qy/y
SalesGAAP$730.5 million
Core sales growthnon-GAAP5.0%5.0%
Cost of salesGAAP$323.5 million
Gross profitGAAP$407.0 million
Selling, general and administrativeGAAP$296.3 million
Research and developmentGAAP$30.4 million
Operating profitGAAP$80.3 million
Other income (expense), netGAAP$2.8 million
Interest expense, netGAAP$(8.7) million
Income before income taxesGAAP$74.4 million
Income tax expenseGAAP$20.7 million
GAAP Net IncomeGAAP$54 million
Adjusted Net Incomenon-GAAP$67 million
Adjusted EBITDAnon-GAAP$108 million+28% year-on-year
Adjusted EBITDA marginnon-GAAP14.7%+230 bps year-on-year
Earnings - basicGAAP$0.33
Earnings - dilutedGAAP$0.33
Adjusted Diluted Earnings Per Sharenon-GAAP$0.41+58% year-on-year
Average common stock and common equivalent shares outstanding - BasicGAAP161.9 million
Average common stock and common equivalent shares outstanding - DilutedGAAP164.1 million
Operating cash flowGAAP$119 million
Free cash flownon-GAAP$105 million
Sales - Six Months Ended July 3, 2026GAAP$1,436.0 million
Cost of sales - Six Months Ended July 3, 2026GAAP$638.9 million
Gross profit - Six Months Ended July 3, 2026GAAP$797.1 million
Selling, general and administrative - Six Months Ended July 3, 2026GAAP$593.9 million
Research and development - Six Months Ended July 3, 2026GAAP$60.4 million
Operating profit - Six Months Ended July 3, 2026GAAP$142.8 million
Other income (expense), net - Six Months Ended July 3, 2026GAAP$(0.1) million
Interest expense, net - Six Months Ended July 3, 2026GAAP$(16.1) million
Income before income taxes - Six Months Ended July 3, 2026GAAP$126.6 million
Income tax expense - Six Months Ended July 3, 2026GAAP$34.2 million
GAAP Net Income - Six Months Ended July 3, 2026GAAP$92 million
Adjusted Net Income - Six Months Ended July 3, 2026non-GAAP$126 million
Adjusted EBITDA - Six Months Ended July 3, 2026non-GAAP$207 million
Earnings - basic - Six Months Ended July 3, 2026GAAP$0.57
Earnings - diluted - Six Months Ended July 3, 2026GAAP$0.56
Adjusted Diluted Earnings Per Share - Six Months Ended July 3, 2026non-GAAP$0.77
Average common stock and common equivalent shares outstanding - Basic - Six Months Ended July 3, 2026GAAP162.9 million
Average common stock and common equivalent shares outstanding - Diluted - Six Months Ended July 3, 2026GAAP165.3 million

Full year 2026 outlook

  • NoteCore Sales Growth: 3.5% to 4.5%
  • NoteAdjusted EBITDA Growth: 11% to 14%
  • NoteAdjusted Diluted Earnings Per Share: $1.50 to $1.55
  • NoteFree Cash Flow Conversion: ~100%

Capital returns

  • During the quarter ended July 3, 2026, we repurchased 2.4 million shares for approximately $59 million.
  • At the end of the quarter, we had approximately $283 million remaining repurchase capacity under our stock repurchase program.

What drove it

  • Both reporting segments delivered positive growth.
  • Specialty Products & Technologies delivered 3.1% core growth.
  • Equipment and Consumables delivered 8.5% core growth.
  • Ongoing contributions from the Envista Business System supported 70 bps of adjusted gross margin expansion and 230 bps of adjusted EBITDA margin expansion.
  • The company cited growth across both reporting segments and all major geographies.

Concerns

  • The company cited macro uncertainty.
  • The filing identifies risks including conditions in the U.S. and global economy, inflation and increasing interest rates, slower economic growth or recession, trade policies and regulations including tariffs, supply-chain disruptions, currency exchange rates, debt obligations, and fluctuations in distributor and customer inventory.

What to watch

  • Delivery against full-year 2026 core sales growth guidance of 3.5% to 4.5%.
  • Delivery against full-year 2026 adjusted EBITDA growth guidance of 11% to 14%.
  • Delivery against full-year 2026 adjusted diluted earnings per share guidance of $1.50 to $1.55.
  • Whether Envista Business System contributions continue to support adjusted gross margin and adjusted EBITDA margin expansion.
  • Free cash flow conversion relative to the ~100% full-year 2026 guidance.

Balance sheet and cash flow

  • Operating cash flow for the second quarter of 2026 was $119 million, compared to $89 million in the second quarter of 2025.
  • Free cash flow for the second quarter of 2026 was $105 million, compared to $76 million in the second quarter of 2025.
  • Cash and cash equivalents: $1,125.6 million as of July 3, 2026; $1,211.7 million as of December 31, 2025.
  • Trade accounts receivable, less allowance for credit losses: $436.9 million as of July 3, 2026; $429.6 million as of December 31, 2025.
  • Inventories, net: $290.9 million as of July 3, 2026; $288.1 million as of December 31, 2025.
  • Total current assets: $1,958.0 million as of July 3, 2026; $2,026.6 million as of December 31, 2025.
  • Property, plant and equipment, net: $295.7 million as of July 3, 2026; $296.8 million as of December 31, 2025.
  • Goodwill: $2,353.5 million as of July 3, 2026; $2,358.2 million as of December 31, 2025.
  • Other intangible assets, net: $613.3 million as of July 3, 2026; $627.2 million as of December 31, 2025.
  • Total assets: $5,597.1 million as of July 3, 2026; $5,679.0 million as of December 31, 2025.
  • Total current liabilities: $807.3 million as of July 3, 2026; $852.6 million as of December 31, 2025.
  • Long-term debt: $1,436.3 million as of July 3, 2026; $1,448.3 million as of December 31, 2025.

Analysis

Envista reported second-quarter sales of $730.5 million and core sales growth of 5.0%. Management said both reporting segments and all major geographies grew. Specialty Products & Technologies posted 3.1% core growth, while Equipment and Consumables posted 8.5% core growth, making Equipment and Consumables the faster-growing reported segment on the disclosed core-growth measure.

Profitability improved substantially from the prior-year quarter. GAAP operating profit was $80.3 million versus $46.3 million, GAAP net income was $54 million versus $26 million, and adjusted EBITDA was $108 million versus $84 million. Adjusted EBITDA margin was 14.7%, up 230 bps year-on-year. Management attributed 70 bps of adjusted gross margin expansion and 230 bps of adjusted EBITDA margin expansion to ongoing contributions from the Envista Business System.

Earnings and cash generation were also stronger. GAAP diluted earnings per share were $0.33 versus $0.16, while adjusted diluted earnings per share were $0.41 versus $0.26, an increase of 58% year-on-year. Operating cash flow was $119 million compared with $89 million, and free cash flow was $105 million compared with $76 million. The company repurchased 2.4 million shares for approximately $59 million and retained approximately $283 million of repurchase capacity.

The balance sheet reported $1,125.6 million of cash and cash equivalents and $1,436.3 million of long-term debt as of July 3, 2026. Cash and cash equivalents were $1,211.7 million and long-term debt was $1,448.3 million as of December 31, 2025. The filing also cited macro uncertainty and a range of risks including economic conditions, trade policies and tariffs, supply-chain disruptions, inventory fluctuations, and currency exchange rates.

Management raised full-year 2026 guidance to 3.5% to 4.5% core sales growth, 11% to 14% adjusted EBITDA growth, and $1.50 to $1.55 of adjusted diluted earnings per share. It maintained free cash flow conversion guidance at ~100%. The raised outlook follows first-half adjusted EBITDA of $207 million, adjusted diluted earnings per share of $0.77, and management's stated continued momentum.

Management, verbatim

We built on our fast start in Q1 with continued good performance in Q2. We delivered growth across both our reporting segments and all major geographies. Our focus on operational excellence, underpinned by the Envista Business System, contributed to further margin expansion. Based on our strong first-half performance and continued momentum, we are raising our full year outlook for core sales growth, adjusted EBITDA, and adjusted EPS. We are well-positioned to deliver another year of progress and performance.

Paul Keel, CEO

Not in the filing

stated, not guessed
  • Segment revenue for Specialty Products & Technologies was not provided in the supplied filing text.
  • Segment revenue for Equipment and Consumables was not provided in the supplied filing text.
  • GAAP gross margin was not provided.
  • Adjusted gross margin was not provided.
  • Quarter-over-quarter comparisons were not provided for reported financial metrics.
  • A previous-release outlook section was not provided; therefore, no formal comparison of actual results against prior guidance is included.
  • Dividend information was not provided.
  • The supplied balance-sheet text is truncated after long-term debt; remaining balance-sheet and equity line items were not available.
  • Forward-looking GAAP guidance was not provided.

AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Background

This is an SEC Form 8-K (Item 2.02) with Envista’s Q2 2026 results and updated full-year 2026 outlook.

Company-level read

Ticker impact

$NVSTBullishHigh confidence
Context

Envista reported Q2 results and raised full-year 2026 guidance for core sales growth, adjusted EBITDA, and adjusted EPS.

Expected impact

Likely positive bias for NVST as traders reprice FY 2026 growth and profitability expectations; follow-through depends on how the raised ranges compare with Street expectations.

Evidence & confidence

The filing discloses specific Q2 performance (sales, EPS, EBITDA margin, free cash flow) and a concrete guidance increase with quantified ranges, which is actionable for earnings-model updates.

Market effects

Dental products and services peers may see read-across on demand durability and margin trajectory if NVST’s guidance raise is viewed as sector-positive.

Limited direct regional spillover stated; growth is described across major geographies.

Global dental market sentiment could improve modestly if margin expansion and cash conversion are interpreted as resilient worldwide.

Counterpoint

Guidance raises may already be partially anticipated; if the raised ranges still imply deceleration or rely on non-GAAP adjustments, the stock reaction could fade.

Key entities

  • Envista Holdings Corporation

    Reported Q2 2026 results and raised FY 2026 guidance for core sales growth, adjusted EBITDA, and adjusted EPS.

  • Paul Keel

    CEO quoted on performance and the rationale for raising full-year outlook.

Every NVST earnings report

This story covers one filing. The ticker page keeps them all: each quarter's reported metrics with year-over-year and sequential comparisons, segments, guidance, and how the numbers landed against the company's own prior outlook.

Related articles

$NVSTMed

BMO reiterates Envista stock rating ahead of investor day

BMO Capital reiterated a Market Perform rating on Envista Holdings (NYSE:NVST) with a $29.00 price target, noting potential upside. The company showed 11.89% revenue growth over the last year, and 11 analysts revised earnings upwards. Envista recently beat Q2 2026 earnings and revenue estimates, raising its full-year outlook. JPMorgan upgraded the stock to Overweight with a $32.00 target, while Mizuho maintained a Neutral rating.

$NVSTHigh

Envista Holdings Shares Rise After JPMorgan Upgrade

Envista Holdings (NVST) shares rose 2.3% premarket after JPMorgan upgraded it to Overweight, raising the price target to $32 from $29. The upgrade comes ahead of Envista's Investor Day on September 17, with JPMorgan expecting improved execution and growth. The analyst anticipates a medium-term core growth range of 2.5% to 4.5%, citing resilient demand despite macroeconomic uncertainty.

$NVSTHigh

Why is Envista stock rallying today?

Envista (NVST) stock rose 2.3% pre-market after JPMorgan upgraded it to Overweight, raising its price target to $32. The bank cited improved execution, resilient demand, and attractive valuation. Envista's Q2 2026 results beat estimates, with adjusted EPS of $0.41 and revenue of $730.5M. The upgrade is ahead of the company's Investor Day on September 17.

$NVSTMed

Envista Holdings stock rises on JPMorgan upgrade

Envista Holdings (NVST) shares rose 2.3% premarket after JPMorgan upgraded them to Overweight with a $32 price target, up from $29. Analyst Lilia-Celine B Lozada cited improved execution, durable growth, and valuation not reflecting fundamentals. The upgrade comes ahead of the company's Investor Day on September 17.

$NVSTHighAI 9/10

Envista (NVST) Q2 2026 Earnings Call Transcript

Envista (NVST) reported Q2 2026 results on an earnings call, citing 5% core growth and sales of $731 million. Adjusted gross margin rose to 55.1%, adjusted EBITDA grew 28% with 14.7% margin, and adjusted EPS was $0.41 (+58%). Free cash flow was $105 million. The company raised 2026 guidance: core growth 3.5% to 4.5%, adjusted EBITDA 11% to 14%, adjusted EPS $1.50 to $1.55.